Pay in 4 interest-free payments of $40.50 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
CDK9-IN-7 also exhibits good inhibition potency with an IC50 value of 0
Solubility: DMSO: 6 mg/mL (Need ultrasonic or warming)
but weakly inhibited the growth of EGFR-overexpressing tumor xenografts
L-165041 promotes VEGF mRNA stabilization in HPV18-harboring HeLa cells through a receptor-independent mechanism
since dopamine is inactivated by norepinephrine reuptake in the frontal cortex
CY-09 G11-azide CDK9-IN-7 also exhibits good inhibitionCY 09 is a selective and direct NLRP3 inhibitor. CY 09 directly binds to the ATP binding motif of NLRP3 NACHT domain and inhibits NLRP3 ATPase activity, resulting in the suppression of NLRP3 inflammasome assembly and activation. Product information CAS Number: 1073612 91 5 Molecular Weight: 423. 43 Formula: C19H12F3NO3S2 Chemical Name: 4 {[(5Z) 4 oxo 2 sulfanylidene 3 {[3 (trifluoromethyl)phenyl]methyl} 1,3 thiazolidin 5 ylidene]methyl}benzoic acid